Home R&D Page 2

R&D

UNION and Innovent collaborate on next-gen PDE4 inhibitor for inflammatory dermatology conditions
Featured

UNION and Innovent collaborate on next-gen PDE4 inhibitor for inflammatory dermatology conditions

Dominic Cuthbert -
0
Syndax and Incyte to develop axatilimab for fibrotic diseases
Featured

Syndax and Incyte to develop axatilimab for fibrotic diseases

Dominic Cuthbert -
0
To support European Healthcare systems post COVID-19, experts call for improved perioperative monitoring to optimise patient safety
Featured

To support European Healthcare systems post COVID-19, experts call for improved perioperative monitoring to optimise patient safety

Dominic Cuthbert -
0
New data on amivantamab in combination with lazertinib show early activity in patients with NSCLC whose disease has progressed after both osimertinib and platinum-based chemo
Featured

New data on amivantamab in combination with lazertinib show early activity in patients with NSCLC whose disease has progressed after both osimertinib and platinum-based chemo

Dominic Cuthbert -
0
Janssen presents results from Phase 1b/2 NORSE study in patients with metastatic or locally advanced urothelial carcinoma treated with erdafitinib in combination with cetrelimab
Featured

Janssen presents results from Phase 1b/2 NORSE study in patients with metastatic or locally advanced urothelial carcinoma treated with erdafitinib in combination with cetrelimab

Dominic Cuthbert -
0
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration
Featured

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration

Dominic Cuthbert -
0
European study highlights the utility of Beckman Coulter’s MDW biomarker for the earlier detection of sepsis in A&E
Featured

European study highlights the utility of Beckman Coulter’s MDW biomarker for the earlier detection of sepsis in A&E

Dominic Cuthbert -
0
Eye care collaboration for AbbVie and REGENXBIO
Featured

Eye care collaboration for AbbVie and REGENXBIO

Dominic Cuthbert -
0
Exscientia and Gates Foundation to develop therapeutics against coronavirus and pandemic potential viruses
Featured

Exscientia and Gates Foundation to develop therapeutics against coronavirus and pandemic potential viruses

Dominic Cuthbert -
0
Adaptimmune and Genentech partner on cancer-targeted allogeneic T-cell therapies
Featured

Adaptimmune and Genentech partner on cancer-targeted allogeneic T-cell therapies

Dominic Cuthbert -
0
123...189Page 2 of 189

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks